Glioblasztóma: vizsgálatok itt: Tajvan
7 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2. fázisNot yet taking people in TajvanThe GLIOMAX Study: MT027 Allogeneic CAR-T for Recurrent Glioma
- Where
- Hualien City, Kaohsiung City, Taoyuan
- Életkor
- 18 év to 70 év
- People
- 40 worldwide
- Run by
- T-MAXIMUM Pharmaceutical Inc
See details and how to joinNCT07386002 - 1/2. fázisTaking peopleA Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Where
- Taipei
- Életkor
- Up to 25 év
- People
- 75 worldwide
- Run by
- Turning Point Therapeutics, Inc.
See details and how to joinNCT04094610 · EU 2023-506464-14-00 - 2. fázisTaking peopleEvaluate the Efficacy and Safety of ADCV01 as an Add-On Treatment for Primary Glioblastoma Multiforme (GBM) Patients
- Where
- Taichung, Taoyuan
- Életkor
- 20 év to 75 év
- People
- 24
- Run by
- Ever Supreme Bio Technology Co., Ltd.
See details and how to joinNCT04115761 - 1/2. fázisTaking peopleA Rollover Study of NBM-BMX in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma
- Where
- Kaohsiung City, Taichung, Taoyuan City
- Életkor
- 18 év and over
- People
- 15
- Run by
- Novelwise Pharmaceutical Corporation
See details and how to joinNCT07569042 - 1/2. fázisTaking peopleNBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma
- Where
- Kaohsiung City, Taichung, Taipei, Taoyuan City
- Életkor
- 18 év and over
- People
- 79
- Run by
- Novelwise Pharmaceutical Corporation
See details and how to joinNCT06012695 - 3. fázisTaking peopleA Prospective Pivotal Study to Evaluate the Efficacy and Safety of Avastin® Bevacizumab (BEV) With or Without Microbubble-mediated Focused Ultrasound (FUS-MB) Using NaviFUS System in Recurrent Glioblastoma Multiforme Patients
- Where
- Taipei, Taoyuan
- Életkor
- 18 év to 80 év
- People
- 32
- Run by
- NaviFUS Corporation
See details and how to joinNCT06496971 - 2. fázisTaking peopleAPL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
- Where
- Taipei
- Életkor
- 18 év and over
- People
- 497 worldwide
- Run by
- Apollomics Inc.
See details and how to joinNCT03175224 · EU 2024-514542-37-00